Columbus Clinical Services LLC

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis3 trials
• Asthma2 trials
• Autism2 trials
• Bipolar disorder2 trials
• COPD2 trials
• Coronary artery disease2 trials
• Familial hypercholesterolaemia2 trials
• Osteoarthritis1 trial
• Schizophrenia1 trial
• Stroke1 trial

Phase

• Phase 39 trials
• Phase 23 trials
• Phase 2/31 trial

Status

• Completed6 trials
• Active, not recruiting4 trials
• Recruiting3 trials

Lead sponsor

• Connect Biopharm LLC3 trials
• Intra-Cellular Therapies, Inc.3 trials
• Janssen Research & Development, LLC2 trials
• Amgen1 trial
• Biosplice Therapeutics, Inc.1 trial
• and 3 more

Running trials

• Recruiting

  Rademikibart IV for Acute Asthma and COPD Exacerbation

  NCT07705737· Phase 2· Connect Biopharm LLC· Source

  Contact: Radha Adivikolanu

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

  NCT06690398· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  NCT06229210· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05528510· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Autism2 recruiting
• Bipolar disorder1 recruiting
• Coronary artery disease1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

  NCT06940154· Phase 2· Connect Biopharm LLC· Source

• Completed

  Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

  NCT06940141· Phase 2· Connect Biopharm LLC· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  NCT06372964· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Completed

  Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES)

  NCT05603754· Phase 3· Biosplice Therapeutics, Inc.· Source

• Completed

  Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

  NCT05142722· Phase 3· NewAmsterdam Pharma· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source